NP-40 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (18)
Papers in which this entity is mentioned.
- Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
- FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. (2025)
- Connectome-seq: High-throughput Mapping of Neuronal Connectivity at Single-Synapse Resolution via Barcode Sequencing. (2025)
- Global impact of unproductive splicing on human gene expression. (2024)
- Joint single-cell measurements of nuclear proteins and RNA in vivo. (2021)
- Simultaneous single cell measurements of intranuclear proteins and gene expression (2021)
- Genetic compensation triggered by mutant mRNA degradation. (2019)
- Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells. (2019)
- Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
- Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. (2017)
- Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
- Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress. (2016)
- Effect of lipid raft disruption on ethanol inhibition of l1 adhesion. (2014)
- Mitogen-activated protein kinase modulates ethanol inhibition of cell adhesion mediated by the L1 neural cell adhesion molecule. (2013)
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. (2013)
- Genomic copy number determination in cancer cells from single nucleotide polymorphism microarrays based on quantitative genotyping corrected for aneuploidy. (2009)
- Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. (2009)
- EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. (1998)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| np-40 | drug | 40 | 54 |
| nonidet p-40 | drug | 14 | 19 |
| 0.02% np-40 | drug | — | — |